3M Tegaderm CHG Dressing for I.V. fixation with chlorhexidine gluconate 1658R, 10x12cm, 25 pcs.
by credit card, Paypal and bank transfer.
with BRT, DPD and FedEx couriers
via Whatsapp + 39.371.43.61.201
3M Tegaderm CHG Fixation Dressing I.V. with Gluconate Chlorhexidine Fixation Dressing 1658R, 10x12cm, 25 pcs.
The integrated I.V. dressing combines infection reduction with site visibility, catheter fixation and breathability.
Proven reduction in catheter-related infections (CRBSI) and vascular catheter colonization.
Immediate and continuous antimicrobial protection thanks to the integrated chlorhexidine gluconate gel buffer, without requiring moisture for activation.
Designed to minimize catheter displacement, it can be worn for up to 7 days.
Waterproof and sterile barrier against external contaminants (liquids, bacteria and viruses).
- The only clearer dressing licensed and tested to reduce CRBSI and vascular catheter colonization
- Integrated design combines infection protection with visibility of the insertion site, correct catheter fixation and uniform application
- CHG's gel buffer provides immediate and continuous antimicrobial protection against microorganisms associated with CRBSI for up to 7 days
- Clear film and gel swab allow continuous site visibility to easily assess early signs of infection
- Device designed to minimize catheter movement and displacement
- Large slotted fastening tape strip promotes correct and consistent application
- Provides antimicrobial action for up to 7 days
- Provides a sterile, waterproof barrier against external contaminants, including liquids, bacteria, and viruses.
- Easy and secure positioning, thanks to the frame application system, minimizes the risk of the dressing sticking to gloves or on itself.
3M Tegaderm CHG - I.V. Chlorhexidine Gluconate Fixation Dressing. The fixation dressing is a new dressing that combines infection reduction, insertion site visibility, uniform application and catheter fixation in one integrated, easy-to-use product. It is the only clear dressing with approved CHG that reduces catheter-related bloodstream infections (CRBSIs) and vascular catheter colonization, in line with evidence-based guidelines and standards of practice.